Figure 2
Figure 2. Evolving paradigms in HSC engineering. (A) Current strategies are restricted by the use of nonclonable adult HSCs. (B) The advent of patient-specific pluripotent stem cells may open new strategies for genetic engineering and biosafety testing.

Evolving paradigms in HSC engineering. (A) Current strategies are restricted by the use of nonclonable adult HSCs. (B) The advent of patient-specific pluripotent stem cells may open new strategies for genetic engineering and biosafety testing.

or Create an Account

Close Modal
Close Modal